Total Payments
$28,329
2024 Payments
$947.17
Companies
42
Transactions
736
Medicare Patients
5,679
Medicare Billing
$478,107
Payment Breakdown by Category
Food & Beverage$12,291 (43.4%)
Consulting$12,000 (42.4%)
Travel$2,171 (7.7%)
Research$1,820 (6.4%)
Education$47.02 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,291 | 718 | 43.4% |
| Consulting Fee | $12,000 | 4 | 42.4% |
| Travel and Lodging | $2,171 | 8 | 7.7% |
| Unspecified | $1,820 | 2 | 6.4% |
| Education | $47.02 | 4 | 0.2% |
Payments by Type
General
$26,509
734 transactions
Research
$1,820
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARALEZ PHARMACEUTICALS US INC. | $13,927 | 24 | $0 (2018) |
| Abbott Laboratories | $1,778 | 6 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,603 | 135 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,479 | 9 | $0 (2020) |
| Amgen Inc. | $1,207 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,021 | 63 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,000 | 69 | $0 (2024) |
| Amarin Pharma Inc. | $897.00 | 66 | $0 (2023) |
| PFIZER INC. | $691.62 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $667.38 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $947.17 | 56 | Novartis Pharmaceuticals Corporation ($168.31) |
| 2023 | $1,197 | 66 | Merck Sharp & Dohme LLC ($288.25) |
| 2022 | $1,123 | 73 | Novartis Pharmaceuticals Corporation ($194.81) |
| 2021 | $1,264 | 89 | Amarin Pharma Inc. ($274.57) |
| 2020 | $4,156 | 87 | Abbott Laboratories ($1,620) |
| 2019 | $1,509 | 88 | AstraZeneca Pharmaceuticals LP ($190.51) |
| 2018 | $1,678 | 111 | Novartis Pharmaceuticals Corporation ($275.42) |
| 2017 | $16,456 | 166 | Aralez Pharmaceuticals US Inc. ($13,913) |
All Payment Transactions
736 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $109.21 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiology | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiology | ||||||
| 07/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| Category: Cardiovascular | ||||||
| 07/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: VTE | ||||||
| 06/12/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: VTE | ||||||
| 06/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $45.18 | General |
| Category: VTE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OPTIS Next Summative Study | Abbott Laboratories | $1,620 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,492 | 2,341 | $1.0M | $126,465 |
| 2022 | 9 | 1,383 | 2,162 | $998,660 | $121,674 |
| 2021 | 12 | 1,466 | 2,309 | $819,576 | $141,433 |
| 2020 | 15 | 1,338 | 1,834 | $306,482 | $88,535 |
Total Patients
5,679
Total Services
8,646
Medicare Billing
$478,107
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 559 | $468,822 | $53,699 | 11.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 362 | $178,879 | $24,782 | 13.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 109 | 109 | $146,515 | $18,944 | 12.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 379 | 632 | $62,182 | $7,214 | 11.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 25 | $29,600 | $3,772 | 12.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $26,117 | $3,348 | 12.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 43 | 51 | $23,349 | $2,956 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $28,478 | $2,925 | 10.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 398 | 440 | $17,720 | $2,911 | 16.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 22 | $18,832 | $2,490 | 13.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $20,697 | $2,081 | 10.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 12 | 18 | $7,088 | $815.24 | 11.5% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 18 | 19 | $2,884 | $369.80 | 12.8% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 19 | 20 | $1,169 | $159.20 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 346 | 608 | $512,714 | $58,297 | 11.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 135 | 137 | $188,858 | $23,577 | 12.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 233 | $105,316 | $14,457 | 13.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 44 | $55,220 | $7,434 | 13.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 355 | 605 | $58,104 | $6,871 | 11.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $33,945 | $4,427 | 13.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 42 | 44 | $20,519 | $2,691 | 13.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 357 | 407 | $14,245 | $2,682 | 18.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 22 | 39 | $7,527 | $962.85 | 12.8% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2022 | 13 | 14 | $2,212 | $276.72 | 12.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 360 | 632 | $361,652 | $64,424 | 17.8% |
About Dr. Alan Lapa, M.D
Dr. Alan Lapa, M.D is a Cardiovascular Disease healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487687794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Lapa, M.D has received a total of $28,329 in payments from pharmaceutical and medical device companies, with $947.17 received in 2024. These payments were reported across 736 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($12,291).
As a Medicare-enrolled provider, Lapa has provided services to 5,679 Medicare beneficiaries, totaling 8,646 services with total Medicare billing of $478,107. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Bloomfield, NJ
- Active Since 07/09/2006
- Last Updated 05/01/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1487687794
Products in Payments
- YOSPRALA (Drug) $13,913
- Optis Coronary Imaging System (Device) $1,620
- ENTRESTO (Drug) $1,306
- Resolute (Device) $1,279
- XARELTO (Drug) $1,000
- Repatha (Biological) $948.79
- ELIQUIS (Drug) $931.09
- Vascepa (Drug) $897.00
- BRILINTA (Drug) $703.34
- VERQUVO (Drug) $667.38
- Impella (Device) $305.24
- WATCHMAN (Device) $293.26
- LEQVIO (Drug) $277.29
- Corlanor (Drug) $258.57
- FARXIGA (Drug) $246.17
- JARDIANCE (Drug) $235.73
- Peripheral Orbital Atherectomy System (Device) $215.59
- PRALUENT (Drug) $199.49
- CHANTIX (Drug) $181.63
- TherOx DS2 Console (Device) $177.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bloomfield
Brett Nowlan, Md, MD
Cardiovascular Disease — Payments: $951,843
Cardiovascular Disease $951,843
Ronald Bloom, M.d, M.D
Cardiovascular Disease — Payments: $30,875
Cardiovascular Disease $30,875
Tracy Patel, M.d, M.D
Cardiovascular Disease — Payments: $13,103
Cardiovascular Disease $13,103
Vincent Romano, M.d, M.D
Cardiovascular Disease — Payments: $11,581
Cardiovascular Disease $11,581
Dr. Catalino Delacruz, M.d, M.D
Cardiovascular Disease — Payments: $10,399
Cardiovascular Disease $10,399
Maria Santos, M.d, M.D
Cardiovascular Disease — Payments: $10,382
Cardiovascular Disease $10,382